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The current pandemic has raised great global public 
health concern. The disease name was subsequently 
recommended as COVID-19 by the World Health 
Organisation (WHO) [1,2]. Meanwhile, 2019-nCoV 
was renamed SARS-CoV-2 by the International Com-
mittee on Taxonomy of Viruses. SARS-CoV-2 is con-
sidered highly contagious. As of April 1, 2020, more 
than 883,255 confirmed cases, including more than 
44,156 deaths, have been reported worldwide, af-
fecting almost the whole world. The distribution of 
countries with confirmed cases of the newly identi-
fied coronavirus SARS-CoV-2 infection as of 1 April 
2020 is presented in Figure 1. Originally the epicentre 
of this ongoing outbreak was located in the city of 
Wuhan in Hubei Province of central China, and the 
Huanan seafood wholesale market was thought to be 
FiguRE 1. Distribution of countries with confirmed cases of the newly identified coronavirus SARS-CoV-2 infection as of 1 April 2020 ac-
cording to the gisanddata.maps.arcgis.com.
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at least one of the places where SARS-CoV-2, from an 
unknown animal source, might have crossed the spe-
cies barrier to infect humans. Italy and Spain are now 
considered the European epicentre of COVID-19; as 
of 1 April 2020, the number of cases in these coun-
tries is as follows: 105,792 and 102,136 confirmed 
infections, and 9,053 and 3,523 deaths, respectively. 
In the USA, the number of confirmed infections ex-
ceeds 189,753 cases. The SARS-CoV-2 coronavirus 
spreads mainly through respiratory droplets. COV-
ID-19 is similar to SARS and MERS in some clinical 
manifestations. In COVID-19 patients, fever, cough, 
and myalgia are the most common symptoms, fol-
lowed by chest distress and shortness of breath. 
However, upper respiratory tract symptoms (e.g. 
nasal congestion, nasal discharge, and sore throat) 
and gastrointestinal symptoms (e.g. abdominal pain 
and diarrhoea) are relatively rare. Fever occurs in 98–
100% of SARS or MERS patients, compared to 81.3% 
of COVID-19 patients in this study [3]. Analysis of 
numerous studies [1, 4–12], covering 1991 patients, 
identified the most common signs and symptoms at 
admission to hospital. These symptoms include: dry 
cough (63.9%), fever (61.7%), fatigue and muscle 
ache (36.9%), anorexia (27.1%), dyspnoea (21.9%), 
headache (13.2%), sore throat (12.0%), chest pain 
(6.4%), confusion (6.1%), rhinorrhoea (6.0%), nausea 
and vomiting (5.8%), and diarrhoea (5.3%). As we 
can observe, the clinical picture of people infected 
with COVID-19 may present itself in a variety of ways; 
however, special attention should be paid to patients 
with such symptoms, and they should be subjected to 
screening and isolation until the results are obtained 
[13,14]. At the same time, it is worth emphasising 
that, as well as searching for a vaccine, it is crucial to 
constantly analyse the existing symptoms in order to 
verify new ones that may be reported by patients and 
which have not yet been taken into account in the 
clinical picture of the patient.
Conflict of interest:
The authors declare that they have no conflict of in-
terest.
Acknowledgements:
Study was supported by the Polish Society of Disas-
ter Medicine. 
REFERENCES
1. Guan WJ, Ni ZY, Hu Yu, et al. China Medical Treatment Expert Group 
for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 
in China. N Engl J Med. 2020 [Epub ahead of print], doi: 10.1056/
NEJMoa2002032, indexed in Pubmed: 32109013.
2. Zhu Na, Zhang D, Wang W, et al. China Novel Coronavirus Investi-
gating and Research Team. A Novel Coronavirus from Patients with 
Pneumonia in China, 2019. N Engl J Med. 2020; 382(8): 727–733, 
doi: 10.1056/NEJMoa2001017, indexed in Pubmed: 31978945.
3. Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, et al. Epidemiological, de-
mographic, and clinical characteristics of 47 cases of Middle East 
respiratory syndrome coronavirus disease from Saudi Arabia: a de-
scriptive study. Lancet Infect Dis. 2013; 13(9): 752–761, doi: 10.1016/
S1473-3099(13)70204-4, indexed in Pubmed: 23891402.
4. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical charac-
teristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, 
China: a descriptive study. The Lancet. 2020; 395(10223): 507–513, 
doi: 10.1016/s0140-6736(20)30211-7.
5. Huang C, Wang Y, Li X, et al. Clinical features of patients infected 
with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020; 
395(10223): 497–506, doi: 10.1016/s0140-6736(20)30183-5.
6. Xu XW, Wu XX, Jiang XG, et al. Clinical findings in a group of patients 
infected with the 2019 novel coronavirus (SARS-Cov-2) outside of 
Wuhan, China: retrospective case series. BMJ. 2020; 368: m606, doi: 
10.1136/bmj.m606, indexed in Pubmed: 32075786.
7. Wang D, Hu Bo, Hu C, et al. Clinical Characteristics of 138 Hospi-
talized Patients With 2019 Novel Coronavirus-Infected Pneumonia 
in Wuhan, China. JAMA. 2020 [Epub ahead of print], doi: 10.1001/
jama.2020.1585, indexed in Pubmed: 32031570.
8. Liu M, He P, Liu HG, et al. [Clinical characteristics of 30 medical 
workers infected with new coronavirus pneumonia]. Zhonghua 
Jie He He Hu Xi Za Zhi. 2020; 43(3): 209–214, doi: 10.3760/cma.
j.issn.1001-0939.2020.03.014, indexed in Pubmed: 32164090.
9. Yuan M, Yin W, Tao Z, et al. Association of radiologic findings with 
mortality of patients infected with 2019 novel coronavirus in Wuhan, 
China. PLoS One. 2020; 15(3): e0230548, doi: 10.1371/journal.
pone.0230548, indexed in Pubmed: 32191764.
10. Chen J, Qi T, Liu Li, et al. Clinical progression of patients with COVID-19 
in Shanghai, China. J Infect. 2020 [Epub ahead of print], doi: 10.1016/j.
jinf.2020.03.004, indexed in Pubmed: 32171869.
11. Mo P, Xing Y, Xiao Yu, et al. Clinical characteristics of refractory COV-
ID-19 pneumonia in Wuhan, China. Clin Infect Dis. 2020 [Epub ahead 
of print], doi: 10.1093/cid/ciaa270, indexed in Pubmed: 32173725.
12. Qian GQ, Yang NB, Ding F, et al. Epidemiologic and Clinical Char-
acteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, 
China: A retrospective, multi-centre case series. QJM. 2020 [Epub 
ahead of print], doi: 10.1093/qjmed/hcaa089, indexed in Pubmed: 
32181807.
13. Smereka J, Szarpak L. COVID 19 a challenge for emergency medicine 
and every health care professional. The American Journal of Emergency 
Medicine. 2020, doi: 10.1016/j.ajem.2020.03.038.
14. Smerek J, Szrpk L, Filipik KJ. Modern medicine in COVID-19 er. Disster 
Emerg Med J 2020. Doi: 10 5603/DEMJ a. 2020; 0012, doi: 10.5603/
DEMJ.a2020.0012.
